Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A minimal genome simian foamy virus type 1 vector system with efficient gene transfer.

Jeonghae Park1, Peter E Nadeau, Ayalew Mergia

  • 1Department of Pathobiology, University of Florida, Gainesville, 32610, USA.

Virology
|November 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Engineering of Lysogenic-Lytic Switch Genes Improves <i>Burkholderia</i> Phage Killing Efficacy.

International journal of molecular sciences·2026
Same author

Antiviral Role of Surface Layer Protein A (SlpA) of <i>Lactobacillus acidophilus</i>.

Pathogens (Basel, Switzerland)·2026
Same author

Complete genome sequence of ceftazidime-resistant <i>Burkholderia pseudomallei</i> strain 490f reveals a complex long repeat region.

Microbiology resource announcements·2025
Same author

Genomic insights into ceftazidime resistance in <i>Burkholderia pseudomallei</i>: discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating <i>penA</i> duplication and amplification.

Antimicrobial agents and chemotherapy·2025
Same author

Current Dengue Virus Vaccine Developments and Future Directions.

Viruses·2025
Same author

The Potential Contribution of Caveolin 1 to HIV Latent Infection.

Pathogens (Basel, Switzerland)·2020
Same journal

Viral etiology of orogenital papillomatosis and squamous cell carcinoma in bottlenose dolphins in the southeastern United States.

Virology·2026
Same journal

Orthoflaviviruses in the modern era: Challenges and breakthroughs.

Virology·2026
Same journal

Post-COVID-19 immune dysregulation and autoimmune sequelae.

Virology·2026
Same journal

GenomoBase: A comprehensive resource for the family Genomoviridae.

Virology·2026
Same journal

Corrigendum to "The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing antibodies". [Virol. 509 [2017] 185-194].

Virology·2026
Same journal

Rapid GeneXpert surveillance of influenza A virus in seabirds and the environment provides early warning for wildlife health in Aotearoa New Zealand.

Virology·2026
See all related articles

Simian foamy virus type 1 (SFV-1) vectors were optimized for gene therapy, identifying a minimal genome for efficient transduction. These SFV-1 vectors can carry large heterologous DNA fragments, enhancing their versatility.

Area of Science:

  • Gene therapy vector development
  • Retroviral vector technology
  • Molecular virology

Background:

  • Foamy viruses possess unique characteristics suitable for developing gene therapy vectors.
  • Simian foamy virus type 1 (SFV-1) is a potential candidate for vector construction.
  • Efficient gene transduction is crucial for effective gene therapy applications.

Purpose of the Study:

  • To establish the minimum simian foamy virus type 1 (SFV-1) vector genome for efficient gene transduction.
  • To determine the payload capacity of SFV-1 vectors for heterologous DNA.
  • To analyze the impact of packaging plasmid constructs on SFV-1 vector production efficiency.

Main Methods:

  • Construction of SFV-1 based vectors and helper plasmids.
  • Deletion analysis of SFV-1 vector genomes.

Related Experiment Videos

  • Green fluorescent protein (GFP) reporter gene assay to assess transduction efficiency.
  • Comparative analysis of different packaging plasmid constructs.

    • Main Results:

    • A minimal SFV-1 vector genome was identified, containing specific regions of the 5' untranslated region, gag, pol, polypurine tract, and 3' LTR.
    • SFV-1 vectors can accommodate a minimum 8930 base-size heterologous DNA fragment.
    • Packaging constructs including the 5' R-U5 region of the LTR are required for optimal SFV-1 vector production, as deletions significantly reduced transduction efficiency.

    Conclusions:

    • Optimized SFV-1 vectors offer a versatile platform for gene therapy due to their minimal genome requirements and substantial payload capacity.
    • The 5' R-U5 region of the LTR in packaging constructs is essential for efficient SFV-1 vector production.
    • Further development of SFV-1 based vectors holds promise for advancing gene therapy strategies.